INTRODUCTION: A major subgroup of patients with acute schizophrenia lacks awareness of having a mental disorder. The aim of this study was to investigate the association of self- and expert-rated insight into illness with subjective quality of life (QOL). It was hypothesised that patients with greater self- and expert-rated insight into illness report lower QOL compared to patients with poor insight. METHOD: For the present study, patients with schizophrenia or schizoaffective disorders were investigated during in-patient treatment. Insight into illness was measured by the scale to assess unawareness of a mental disorder (SUMD), the insight scale and the PANSS. QOL was assessed with the modular system of quality of life (MSQoL). Results Fifty-nine patients entered the study. Self- and expert-rated illness insight were associated with poor QOL. Patients with good insight into illness reported significantly lower physical health (p < 0.05), vitality (p < 0.01), psychosocial (p < 0.01), affective (p < 0.01) and general QOL (p < 0.001) compared to patients with poor insight. Good insight was significantly associated with other parameters of clinical and social functioning and depressive symptoms. DISCUSSION: The results indicate that patients with acute schizophrenia and greater insight realise their restrictions more clearly, which contribute to poor QOL, but were stronger integrated in social networks. The inclusion of modules focussing on QOL related aspects of treatment from the beginning as well as a greater awareness of the physician for these questions and a strengthening of the therapeutic alliance might help improving insight without the risk of deteriorating mood and QOL.
INTRODUCTION: A major subgroup of patients with acute schizophrenia lacks awareness of having a mental disorder. The aim of this study was to investigate the association of self- and expert-rated insight into illness with subjective quality of life (QOL). It was hypothesised that patients with greater self- and expert-rated insight into illness report lower QOL compared to patients with poor insight. METHOD: For the present study, patients with schizophrenia or schizoaffective disorders were investigated during in-patient treatment. Insight into illness was measured by the scale to assess unawareness of a mental disorder (SUMD), the insight scale and the PANSS. QOL was assessed with the modular system of quality of life (MSQoL). Results Fifty-nine patients entered the study. Self- and expert-rated illness insight were associated with poor QOL. Patients with good insight into illness reported significantly lower physical health (p < 0.05), vitality (p < 0.01), psychosocial (p < 0.01), affective (p < 0.01) and general QOL (p < 0.001) compared to patients with poor insight. Good insight was significantly associated with other parameters of clinical and social functioning and depressive symptoms. DISCUSSION: The results indicate that patients with acute schizophrenia and greater insight realise their restrictions more clearly, which contribute to poor QOL, but were stronger integrated in social networks. The inclusion of modules focussing on QOL related aspects of treatment from the beginning as well as a greater awareness of the physician for these questions and a strengthening of the therapeutic alliance might help improving insight without the risk of deteriorating mood and QOL.
Authors: Danny Koren; Larry J Seidman; Michael Poyurovsky; Morris Goldsmith; Polina Viksman; Suzi Zichel; Ehud Klein Journal: Schizophr Res Date: 2004-10-01 Impact factor: 4.939
Authors: Alex Hofer; Maria A Rettenbacher; Christian G Widschwendter; Georg Kemmler; Martina Hummer; W Wolfgang Fleischhacker Journal: Eur Arch Psychiatry Clin Neurosci Date: 2005-11-29 Impact factor: 5.270
Authors: Anne Karow; Joerg Czekalla; Ralf W Dittmann; Alexander Schacht; Thomas Wagner; Martin Lambert; Benno G Schimmelmann; Dieter Naber Journal: J Clin Psychiatry Date: 2007-01 Impact factor: 4.384
Authors: Piotr J Quee; Lisette van der Meer; Richard Bruggeman; Lieuwe de Haan; Lydia Krabbendam; Wiepke Cahn; Niels C L Mulder; Durk Wiersma; André Aleman Journal: Schizophr Bull Date: 2010-11-22 Impact factor: 9.306
Authors: Min Dong; Li Lu; Ling Zhang; Yun-Shu Zhang; Chee H Ng; Gabor S Ungvari; Gang Li; Xiangfei Meng; Gang Wang; Yu-Tao Xiang Journal: Psychiatr Q Date: 2019-09
Authors: Adrienne Nevola; Michael E Morris; Holly C Felix; Teresa Hudson; Nalin Payakachat; J Mick Tilford Journal: Qual Life Res Date: 2020-11-19 Impact factor: 4.147
Authors: Michelle H Lim; John F M Gleeson; Mario Alvarez-Jimenez; David L Penn Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-01-11 Impact factor: 4.328
Authors: Fernando Cañas; Koksal Alptekin; Jean Michel Azorin; Vincent Dubois; Robin Emsley; Antonio G García; Philip Gorwood; Peter M Haddad; Dieter Naber; José M Olivares; Georgios Papageorgiou; Miquel Roca Journal: Clin Drug Investig Date: 2013-02 Impact factor: 2.859